Menu
Quick summary – Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
| Duration (mins) | Session title | Faculty |
|---|---|---|
| 5 | Welcome and introductions | Michael Böhm |
| 10 | The growing burden of hypertensive nephropathy | Michael Böhm |
| 20 | The how, why, and who of SGLT2 inhibitors | David Wheeler |
| 15 | Breaking guideline updates | Pantelis Sarafidis |
| 15 | A pragmatic approach to coordinating care | Ana Cebrian |
| 20 | Panel discussion and Q&A | All faculty |
| 5 | Summary and close | Michael Böhm |
Please note you must register for the 32nd European Meeting on Hypertension and Cardiovascular Protection to access this event.Register for ESH conference here: https://esh2023.eu/
The educational content is intended for Cardiologists.
This educational programme has been endorsed by ESH committee, who have reviewed and endorsed the programme content for its scientific and educational quality.
Supported by an unrestricted educational grant from AstraZeneca.
